Infliximab use in Crohn's disease:impact on health care resources in the UK

Jewell, Derek P, Satsangi, Jack, Lobo, Alan, Probert, Christopher, Forbes, Alastair, Ghosh, Subrata, Shaffer, Jon, Frenz, Markus, Drummond, Hazel, Troy, Gill, Turner, Sue, Younge, Lisa, Evans, Lyn, Moosa, Mark, Rodgers-Gray, Barry and Buchan, Scot (2005) Infliximab use in Crohn's disease:impact on health care resources in the UK. European Journal of Gastroenterology & Hepatology, 17 (10). pp. 1047-52. ISSN 0954-691X

Full text not available from this repository. (Request a copy)

Abstract

To quantify the impact of infliximab therapy on health care resource utilization in the UK.

Item Type: Article
Uncontrolled Keywords: adolescent,adult,aged,aged, 80 and over,antibodies, monoclonal,antirheumatic agents,cost-benefit analysis,crohn disease,drug costs,epidemiologic methods,female,great britain,health care costs,health resources,health services research,hospitalization,humans,male,middle aged,treatment outcome,tumor necrosis factor-alpha
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 06 Aug 2014 11:48
Last Modified: 11 Apr 2019 15:41
URI: https://ueaeprints.uea.ac.uk/id/eprint/49639
DOI:

Actions (login required)

View Item